Ccr5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccr5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCR6 Human Pre-designed siRNA Set A contains three designed siRNAs for CCR6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccr6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccr6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCR7 Human Pre-designed siRNA Set A contains three designed siRNAs for CCR7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccr7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccr7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCR8 antagonist 3 (compound 2) is a CCR8 antagonist with an IC50 value of 0.062 µM. CCR8 antagonist 3 shows human microsomal stability[1].

CCR8 Human Pre-designed siRNA Set A contains three designed siRNAs for CCR8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr8 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccr8 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr8 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccr8 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCR9 Human Pre-designed siRNA Set A contains three designed siRNAs for CCR9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr9 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccr9 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccr9 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccr9 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCRL2 Human Pre-designed siRNA Set A contains three designed siRNAs for CCRL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCS Human Pre-designed siRNA Set A contains three designed siRNAs for CCS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCSAP Human Pre-designed siRNA Set A contains three designed siRNAs for CCSAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCSER1 Human Pre-designed siRNA Set A contains three designed siRNAs for CCSER1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCT2 Human Pre-designed siRNA Set A contains three designed siRNAs for CCT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCT4 Human Pre-designed siRNA Set A contains three designed siRNAs for CCT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCT5 Human Pre-designed siRNA Set A contains three designed siRNAs for CCT5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCT6A Human Pre-designed siRNA Set A contains three designed siRNAs for CCT6A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCT7 Human Pre-designed siRNA Set A contains three designed siRNAs for CCT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCT8 Human Pre-designed siRNA Set A contains three designed siRNAs for CCT8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for CCZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD 10899 is a hydroxylated metabolite of Volasertib (HY-12137). CD 10899 is pharmacologically active against Polo-like kinase 1 (PLK1) (IC50: 6 nM). Volasertib is an orally active, highly potent and ATP-competitive PLK1 inhibitor. CD 10899 can be used for research of cancer[1].

CD109 Human Pre-designed siRNA Set A contains three designed siRNAs for CD109 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD14 Human Pre-designed siRNA Set A contains three designed siRNAs for CD14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD151 Human Pre-designed siRNA Set A contains three designed siRNAs for CD151 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD160 Human Pre-designed siRNA Set A contains three designed siRNAs for CD160 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD163 Human Pre-designed siRNA Set A contains three designed siRNAs for CD163 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD163L1 Human Pre-designed siRNA Set A contains three designed siRNAs for CD163L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD164 Human Pre-designed siRNA Set A contains three designed siRNAs for CD164 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD164L2 Human Pre-designed siRNA Set A contains three designed siRNAs for CD164L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.